Transposons: Unexpected players in cancer

dc.contributor.authorPradhan, Rajesh Kumar
dc.contributor.authorRamakrishna, Wusirika
dc.date.accessioned2024-01-16T14:23:10Z
dc.date.accessioned2024-08-13T10:34:08Z
dc.date.available2024-01-16T14:23:10Z
dc.date.available2024-08-13T10:34:08Z
dc.date.issued2021-09-27T00:00:00
dc.description.abstractTransposons are repetitive DNA sequences encompassing about half of the human genome. They play a vital role in genome stability maintenance and contribute to genomic diversity and evolution. Their activity is regulated by various mechanisms considering the deleterious effects of these mobile elements. Various genetic risk factors and environmental stress conditions affect the regulatory pathways causing alteration of transposon expression. Our knowledge of the biological role of transposons is limited especially in various types of cancers. Retrotransposons of different types (LTR-retrotransposons, LINEs and SINEs) regulate a plethora of genes that have a role in cell reprogramming, tumor suppression, cell cycle, apoptosis, cell adhesion and migration, and DNA repair. The regulatory mechanisms of transposons, their deregulation and different mechanisms underlying transposon-mediated carcinogenesis in humans focusing on the three most prevalent types, lung, breast and colorectal cancers, were reviewed. The modes of regulation employed include alternative splicing, deletion, insertion, duplication in genes and promoters resulting in upregulation, downregulation or silencing of genes. � 2021 Elsevier B.V.en_US
dc.identifier.doi10.1016/j.gene.2021.145975
dc.identifier.issn3781119
dc.identifier.urihttps://doi.org/10.1016/j.gene.2021.145975
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/2862
dc.language.isoen_USen_US
dc.publisherElsevier B.V.en_US
dc.subjectCanceren_US
dc.subjectGene regulationen_US
dc.subjectRetrotransposonsen_US
dc.titleTransposons: Unexpected players in canceren_US
dc.title.journalGeneen_US
dc.typeReviewen_US
dc.type.accesstypeClosed Accessen_US

Files